{"id":"W2411638242","doi":"10.1007/s11060-016-2155-4","title":"Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study","year":2016,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma Global Development","keywords":"Medicine; Erlotinib; Etoposide; Internal medicine; Randomized controlled trial; Oncology; Surgery; Gastroenterology; Chemotherapy; Epidermal growth factor receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002036951,0.002257352,0.005374454,0.0005357282,0.0005478758,0.001680245,0.001346945,0.002008778,0.004792748],"category_scores_gemma":[0.002246136,0.0009801801,0.002789381,0.0006235535,0.001897632,0.00287132,0.0005540517,0.004249548,0.0009186797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001256635,"about_ca_system_score_gemma":0.001284464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009263001,"about_ca_topic_score_gemma":0.001952356,"domain_scores_codex":[0.9990079,0.0004823692,0.00008255561,0.0001882631,0.00006798219,0.0001710205],"domain_scores_gemma":[0.9984747,0.0004943729,0.0003299372,0.0001746626,0.00008388975,0.0004424558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9834327,0.005074518,0.000452353,0.0003328041,0.0007673881,0.00003841123,0.00003692714,0.0002720935,0.001103173,0.00005503855,0.0002180956,0.008216455],"study_design_scores_gemma":[0.8992943,0.09685969,0.001430795,0.00003856316,0.0009752714,0.00004921084,0.00004498818,0.0003988381,0.000344907,0.0001265372,0.00041199,0.00002496435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914158,0.003956298,0.000526384,0.000371097,0.0004703474,0.001679642,0.0006582888,0.00005922554,0.0008628819],"genre_scores_gemma":[0.9904673,0.003320276,0.001001845,0.0005487942,0.0004796646,0.001927598,0.0007493233,0.00002544171,0.001479978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005374454,"threshold_uncertainty_score":0.01603335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1056974383727223,"score_gpt":0.4132313048433015,"score_spread":0.3075338664705791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}